In a pilot trial, the upregulation of BMP4 mRNA levels in chronic inactive MS lesions as compared to control brain tissue was demonstrated in frozen sections of four MS patients and four controls using qPCR (Figure 1A). Here, BMP4 is linked to myeloid sarcoma.